Synthetic high-density lipoproteins for delivery of 10-hydroxycamptothecin

References

• MooberryLKNairMParanjapeSMcConathyWJLackoAGReceptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrierJ Drug Target2010181535819637935
   PubMed Web of Science ®Google Scholar
• RosensonRSBrewerHBJrDavidsonWSCholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transportCirculation2012125151905191922508840
   PubMed Web of Science ®Google Scholar
• KingwellBAChapmanMJKontushAMillerNEHDL-targeted therapies: progress, failures and futureNat Rev Drug Discov201413644546424854407
   PubMed Web of Science ®Google Scholar
• KrauseBRRemaleyATReconstituted HDL for the acute treatment of acute coronary syndromeCurr Opin Lipidol201324648048624184938
   PubMed Web of Science ®Google Scholar
• KuaiRLiDChenYEMoonJJSchwendemanAHigh-density lipoproteins: nature’s multifunctional nanoparticlesAcs Nano20161033015304126889958
   PubMed Web of Science ®Google Scholar
• JiaJXiaoYLiuJPreparation, characterizations, and in vitro metabolic processes of paclitaxel-loaded discoidal recombinant high-density lipoproteinsJ Pharm Sci201210182900290822628199
   PubMed Web of Science ®Google Scholar
• ZhangXChenBRecombinant high density lipoprotein reconstituted with apolipoprotein AI cysteine mutants as delivery vehicles for 10-hydroxycamptothecinCancer Lett20102981263320579804
   PubMed Web of Science ®Google Scholar
• SinghATEvensAMAndersonRJAll trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphomaBr J Haematol2010150215816920507312
   PubMed Web of Science ®Google Scholar
• GhoshMSinghATXuWSulchekTGordonLIRyanROCurcumin nanodisks: formulation and characterizationNanomedicine20117216216720817125
   PubMed Web of Science ®Google Scholar
• GlicksonJDLund-KatzSZhouRLipoprotein nanoplatform for targeted delivery of diagnostic and therapeutic agentsMol Imaging20087210111018706292
   PubMed Web of Science ®Google Scholar
• CuiLLinQJinCSA PEGylation-Free Biomimetic Porphyrin Nanoplatform for Personalized Cancer TheranosticsACS Nano2015944484449525830219
   PubMed Web of Science ®Google Scholar
• GullottiEYeoYExtracellularly activated nanocarriers: a new paradigm of tumor targeted drug deliveryMol Pharm2009641041105119366234
   PubMed Web of Science ®Google Scholar
• RemaleyATAmarMSviridovDHDL-replacement therapy: mechanism of action, types of agents and potential clinical indicationsExp Rev Cardiovasc Ther20086912031215
   PubMedGoogle Scholar
• YangMJinHLChenJAEfficient cytosolic delivery of siRNA using HDL-mimicking nanoparticlesSmall20117556857321370456
   PubMed Web of Science ®Google Scholar
• AmarMJD’SouzaWTurnerS5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in miceJ Pharmacol Exp Ther2010334263464120484557
   PubMed Web of Science ®Google Scholar
• WallMECamptothecin and taxol: discovery to clinicMed Res Rev19981852993149735871
   PubMed Web of Science ®Google Scholar
• WangALiSHydroxycamptothecin-loaded nanoparticles enhance target drug delivery and anticancer effectBMC Biotechnol200884618454874
   PubMed Web of Science ®Google Scholar
• MiZBurkeTGDifferential interactions of camptothecin lactone and carboxylate forms with human blood componentsBiochemistry1994333410325103368068669
   PubMed Web of Science ®Google Scholar
• ShiKTianYJiangYWangLCuiFModified hydrolysis kinetics of the active lactone moiety of 10-hydroxycamptothecin by liposomal encapsulationPharm Dev Technol201015664465219943738
   PubMed Web of Science ®Google Scholar
• LundbergBBBiologically active camptothecin derivatives for incorporation into liposome bilayers and lipid emulsionsAnticancer Drug Des19981354534619702210
   PubMedGoogle Scholar
• YangLCuiFCunDTaoAShiKLinWPreparation, characterization and biodistribution of the lactone form of 10-hydroxycamptothecin (HCPT)-loaded bovine serum albumin (BSA) nanoparticlesInt J Pharm20073401–216317217482779
   PubMed Web of Science ®Google Scholar
• TongWWangLD’SouzaMJEvaluation of PLGA microspheres as delivery system for antitumor agent-camptothecinDrug Dev Ind Pharm200329774575612906332
   PubMed Web of Science ®Google Scholar
• LiuJJiangZZZhangSMSaltzmanWMPoly(omega-pentadecalactone-co-butylene-co-succinate) nanoparticles as biodegradable carriers for camptothecin deliveryBiomaterials200930295707571919632718
   PubMed Web of Science ®Google Scholar
• WarnerDLBurkeTGSimple and versatile high-performance liquid chromatographic method for the simultaneous quantitation of the lactone and carboxylate forms of camptothecin anticancer drugsJ Chromatogr B Biomed Sci Appl199769111611719140770
   PubMedGoogle Scholar
• ZhaoYXLiuDXLiangWQYeZWIn-vivo pharmacokinetics, tissue distribution and anti-tumour effect of hydroxycamptothecin delivered in oil-in-water submicron emulsionsJ Pharm Pharmacol201264678379122571256
   PubMed Web of Science ®Google Scholar
• KontushALhommeMChapmanMJUnraveling the complexities of the HDL lipidomeJ Lipid Res201354112950296323543772
   PubMed Web of Science ®Google Scholar
• Ohvo-RekilaHRamstedtBLeppimakiPSlotteJPCholesterol interactions with phospholipids in membranesProg Lipid Res2002411669711694269
   PubMed Web of Science ®Google Scholar
• RamstedtBSlotteJPInteraction of cholesterol with sphingomyelins and acyl-chain-matched phosphatidylcholines: a comparative study of the effect of the chain lengthBiophys J19997629089159929492
   PubMed Web of Science ®Google Scholar
• SchwendemanASviridovDOYuanWThe effect of phospholipid composition of reconstituted HDL on its cholesterol efflux and anti-inflammatory propertiesJ Lipid Res20155691727173726117661
   PubMed Web of Science ®Google Scholar
• SilviusJRMcElhaneyRNMolecular properties of membrane lipids and activity of a membrane adenosine triphosphatase from Acholeplasma laidlawii BRev Infect Dis19824SupplS50S586214837
   PubMedGoogle Scholar
• BarenholzYThomasTESphingomyelin: biophysical aspectsChem Phy Lipids19991021–22934
   PubMed Web of Science ®Google Scholar
• van AntwerpenRChenGCPullingerCRCryo-electron microscopy of low density lipoprotein and reconstituted discoidal high density lipoprotein: imaging of the apolipoprotein moietyJ Lipid Res19973846596699144081
   PubMed Web of Science ®Google Scholar
• TianQZhangJTanTMHuman multidrug resistance associated protein 4 confers resistance to camptothecinsPharm Res200522111837185316132345
   PubMed Web of Science ®Google Scholar
• YanceyPGde la Llera-MoyaMSwarnakarSHigh density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BIJ Biol Chem200027547365963660410964930
   PubMed Web of Science ®Google Scholar
• SubramanianCKuaiRZhuQSynthetic high-density lipoprotein nanoparticles: A novel therapeutic strategy for adrenocortical carcinomasSurgery2016159128429426582501
   PubMed Web of Science ®Google Scholar
• ZhengYLiuYJinHScavenger receptor B1 is a potential biomarker of human nasopharyngeal carcinoma and its growth is inhibited by HDL-mimetic nanoparticlesTheranostics20133747748623843895
   PubMed Web of Science ®Google Scholar
• WasanKMBrocksDRLeeSDSachs-BarrableKThorntonSJImpact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discoveryNat Rev Drug Discov200871849918079757
   PubMed Web of Science ®Google Scholar
• de VruehRL RESliedregtLABiessenEAvan BerkelTJBijsterboschMKSynthesis of a lipophilic prodrug of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) and its incorporation into a hepatocyte-specific lipidic carrierPharm Res19991681179118510468017
   PubMed Web of Science ®Google Scholar
• NikanjamMGibbsARHuntCABudingerTFForteTMSynthetic nano-LDL with paclitaxel oleate as a targeted drug delivery vehicle for glioblastoma multiformeJ Control Release2007124316317117964677
   PubMed Web of Science ®Google Scholar